Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 323,800 | 251,100 | 210,000 | 83,600 | 56,800 |
| Receivables | 302,300 | 267,300 | 239,000 | 211,600 | 271,400 |
| Inventories | 263,800 | 176,000 | 131,300 | 147,300 | 162,700 |
| Income taxes - deferred | 23,300 | 26,800 | 17,300 | 22,100 | 42,600 |
| Other current assets | 29,300 | 8,800 | 7,200 | 8,000 | 34,300 |
| TOTAL | $942,500 | $730,000 | $604,800 | $472,600 | $567,800 |
| Non-Current Assets | |||||
| PPE Net | 678,600 | 662,900 | 577,900 | 598,000 | 616,200 |
| Investments And Advances | 85,500 | 82,100 | 90,400 | 92,600 | 94,800 |
| Intangibles | 409,200 | 409,600 | 373,500 | 376,100 | 384,400 |
| Other Non-Current Assets | 135,800 | 141,300 | 119,800 | 111,100 | 58,400 |
| TOTAL | $1,309,100 | $1,295,900 | $1,161,600 | $1,177,800 | $1,153,800 |
| Total Assets | $2,251,600 | $2,025,900 | $1,766,400 | $1,650,400 | $1,721,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 119,000 | 9,300 | 99,900 | N/A | N/A |
| Accounts payable and accrued liabilities | 138,100 | 93,500 | 99,500 | 75,800 | 111,000 |
| Accrued Expenses | 178,100 | 170,500 | 175,800 | 157,800 | 179,600 |
| TOTAL | $496,700 | $336,500 | $445,700 | $282,000 | $358,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 300,100 | 416,200 | 216,000 | 314,700 | 313,400 |
| Other Non-Current Liabilities | 522,800 | 517,800 | 481,800 | 416,800 | 433,100 |
| TOTAL | $822,900 | $934,000 | $697,800 | $731,500 | $746,500 |
| Total Liabilities | $1,319,600 | $1,270,500 | $1,143,500 | $1,013,500 | $1,105,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,801 | 78,314 | 77,690 | 79,320 | N/A |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | 1,108,500 | 982,900 | 905,500 | 826,200 | 755,100 |
| Other shareholders' equity | -38,800 | -63,300 | -123,300 | -55,600 | -38,200 |
| TOTAL | $932,000 | $755,400 | $622,900 | $636,900 | $616,200 |
| Total Liabilities And Equity | $2,251,600 | $2,025,900 | $1,766,400 | $1,650,400 | $1,721,600 |